Insulin-like growth factor system on adrenocortical tumorigenesis

Molecular and Cellular Endocrinology

Volumn 351, Issue 1, 2012, Pages 96-100

  Ribeiro, Tamaya Castro ^a   Latronico, Ana Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Beckwith Wiedemann syndrome; IGF system; IGF 1R; IGF2; IGFBPs; Sporadic adrenocortical tumors

Indexed keywords

NVP AEW 541; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ADRENAL CORTEX CARCINOMA; ANTINEOPLASTIC ACTIVITY; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME 11P; DRUG TARGETING; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GENE REARRANGEMENT; H19 GENE; HUMAN; IGF GENE; IGF1R GENE; IGF2 GENE; MARKER GENE; ONCOGENE; P57KIP2 GENE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; BECKWITH-WIEDEMANN SYNDROME; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; CYCLIN-DEPENDENT KINASE INHIBITOR P57; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; INSULIN-LIKE GROWTH FACTOR II; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84857115148     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.09.042     Document Type: Review

References (66)

1. Abbott A.M., Bueno R., Pedrini M.T., Murray J.M., Smith R.J. Insulin-like growth factor I receptor gene structure. J. Biol. Chem. 1992, 267:10759-10763.
2. Almeida M.Q., Fragoso M.C., Lotfi C.F., Santos M.G., Nishi M.Y., Costa M.H., Lerario A.M., Maciel C.C., Mattos G.E., Jorge A.A., Mendonca B.B., Latronico A.C. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. J. Clin. Endocrinol. Metab. 2008, 93:3524-3531.
3. Barlaskar F.M., Spalding A.C., Heaton J.H., Kuick R., Kim A.C., Thomas D.G., Giordano T.J., Ben-Josef E., Hammer G.D. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 2009, 94:204-212.
4. Bergmann U., Funatomi H., Yokoyama M., Beger H.G., Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res. 1995, 55:2007-2011.
5. Bertherat J., Bertagna X. Pathogenesis of adrenocortical cancer. Best Pract. Res. Clin. Endocrinol. Metab. 2009, 23:261-271.
6. Boulle N., Logie A., Gicquel C., Perin L., Le Bouc Y. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 1998, 83:1713-1720.
7. Boulle N., Baudin E., Gicquel C., Logie A., Bertherat J., Penfornis A., Bertagna X., Luton J.P., Schlumberger M., Le Bouc Y. Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur. J. Endocrinol. 2001, 144:29-36.
8. Brannan C.I., Dees E.C., Ingram R.S., Tilghman S.M. The product of the H19 gene may function as an RNA. Mol. Cell Biol. 1990, 10:28-36.
9. Butler A.A., Yakar S., Gewolb I.H., Karas M., Okubo Y., LeRoith D. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 1998, 121:19-26.
10. Callan, A.C. and Milne, E., 2009. Involvement of the IGF system in fetal growth and childhood cancer: an overview of potential mechanisms. Cancer Causes Control.
11. Chan J.M., Stampfer M.J., Giovannucci E., Gann P.H., Ma J., Wilkinson P., Hennekens C.H., Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998, 279:563-566.
12. Claussen M., Kubler B., Wendland M., Neifer K., Schmidt B., Zapf J., Braulke T. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 1997, 138:3797-3803.
13. Coverley J.A., Baxter R.C. Phosphorylation of insulin-like growth factor binding proteins. Mol. Cell Endocrinol. 1997, 128:1-5.
14. de Fraipont F., El Atifi M., Cherradi N., Le Moigne G., Defaye G., Houlgatte R., Bertherat J., Bertagna X., Plouin P.F., Baudin E., Berger F., Gicquel C., Chabre O., Feige J.J. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab. 2005, 90:1819-1829.
15. DeChiara T.M., Robertson E.J., Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991, 64:849-859.
16. Doghman M., Wakil A.E., Cardinaud B., Thomas E., Wang J., Zhao W., Peralta-Del Valle M.H., Figueiredo B.C., Zambetti G.P., Lalli E. Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microrna in childhood adrenocortical tumors. Cancer Res. 2010, 70:4666-4675.
17. Fassnacht M., Libe R., Kroiss M., Allolio B. Adrenocortical carcinoma: a clinician's update. Nat. Rev. Endocrinol 2011.
18. Fottner C., Engelhardt D., Weber M.M. Regulation of steroidogenesis by insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I and, more potently, IGF-II preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins. J. Endocrinol. 1998, 158:409-417.
19. Fottner C., Engelhardt D., Weber M.M. Characterization of insulin-like growth factor binding proteins (IGFBPs) secreted by bovine adrenocortical cells in primary culture: regulation by insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH). Horm. Metab. Res. 1999, 31:203-208.
20. Fottner C., Engelhardt D., Elmlinger M.W., Weber M.M. Identification and characterization of insulin-like growth factor (IGF)-binding protein expression and secretion by adult human adrenocortical cells: differential regulation by IGFs and adrenocorticotropin. J. Endocrinol. 2001, 168:465-474.
21. Fottner C., Hoeflich A., Wolf E., Weber M.M. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm. Metab. Res. 2004, 36:397-405.
22. Gaston V., Le Bouc Y., Soupre V., Burglen L., Donadieu J., Oro H., Audry G., Vazquez M.P., Gicquel C. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 2001, 9:409-418.
23. Gicquel C., Bertagna X., Schneid H., Francillard-Leblond M., Luton J.P., Girard F., Le Bouc Y. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 1994, 78:1444-1453.
24. Gicquel C., Raffin-Sanson M.L., Gaston V., Bertagna X., Plouin P.F., Schlumberger M., Louvel A., Luton J.P., Le Bouc Y. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 1997, 82:2559-2565.
25. Gicquel C., Bertagna X., Gaston V., Coste J., Louvel A., Baudin E., Bertherat J., Chapuis Y., Duclos J.M., Schlumberger M., Plouin P.F., Luton J.P., Le Bouc Y. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001, 61:6762-6767.
26. Giordano T.J., Thomas D.G., Kuick R., Lizyness M., Misek D.E., Smith A.L., Sanders D., Aljundi R.T., Gauger P.G., Thompson N.W., Taylor J.M., Hanash S.M. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003, 162:521-531.
27. Goda N., Tenno T., Inomata K., Shirakawa M., Tanaka T., Hiroaki H. Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5. Exp. Cell Res. 2008, 314:2352-2361.
28. Hankinson S.E., Willett W.C., Colditz G.A., Hunter D.J., Michaud D.S., Deroo B., Rosner B., Speizer F.E., Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998, 351:1393-1396.
29. Hao Y., Crenshaw T., Moulton T., Newcomb E., Tycko B. Tumour-suppressor activity of H19 RNA. Nature 1993, 365:764-767.
30. Hellawell G.O., Turner G.D., Davies D.R., Poulsom R., Brewster S.F., Macaulay V.M. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease. Cancer Res. 2002, 62:2942-2950.
31. Hoeflich A., Fettscher O., Lahm H., Blum W.F., Kolb H.J., Engelhardt D., Wolf E., Weber M.M. Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cells. Cancer Res. 2000, 60:834-838.
32. Hoeflich A., Fettscher O., Preta G., Lahm H., Kolb H.J., Wolf E., Weber M.M. Increased activity of catalase in tumor cells overexpressing IGFBP-2. Horm. Metab. Res. 2003, 35:816-821.
33. Horney M.J., Shirley D.W., Kurtz D.T., Rosenzweig S.A. Elevated glucose increases mesangial cell sensitivity to insulin-like growth factor I. Am. J. Physiol. 1998, 274:F1045-F1053.
34. Hwa V., Oh Y., Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr. Rev. 1999, 20:761-787.
35. Ilvesmaki V., Kahri A.I., Miettinen P.J., Voutilainen R. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. J. Clin. Endocrinol. Metab. 1993, 77:852-858.
36. Ilvesmaki V., Blum W.F., Voutilainen R. Insulin-like growth factor binding proteins in the human adrenal gland. Mol. Cell Endocrinol. 1993, 97:71-79.
37. Ilvesmaki V., Liu J., Heikkila P., Kahri A.I., Voutilainen R. Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas. Horm. Metab. Res. 1998, 30:619-623.
38. Kamio T., Shigematsu K., Kawai K., Tsuchiyama H. Immunoreactivity and receptor expression of insulin like growth factor I and insulin in human adrenal tumors. An immunohistochemical study of 94 cases. Am. J. Pathol. 1991, 138:83-91.
39. Kanter-Lewensohn L., Dricu A., Girnita L., Wejde J., Larsson O. Expression of insulin-like growth factor-1 receptor (IGF-1R) and p27Kip1 in melanocytic tumors: a potential regulatory role of IGF-1 pathway in distribution of p27Kip1 between different cyclins. Growth Factors 2000, 17:193-202.
40. Kelley K.M., Oh Y., Gargosky S.E., Gucev Z., Matsumoto T., Hwa V., Ng L., Simpson D.M., Rosenfeld R.G. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int. J. Biochem. Cell Biol. 1996, 28:619-637.
41. Leboulleux S., Gaston V., Boulle N., Le Bouc Y., Gicquel C. Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis. Eur. J. Endocrinol. 2001, 144:163-168.
42. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
43. Maher E.R., Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J. Clin. Invest. 2000, 105:247-252.
44. Matsuoka S., Edwards M.C., Bai C., Parker S., Zhang P., Baldini A., Harper J.W., Elledge S.J. P57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995, 9:650-662.
45. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 1997, 18:378-403.
46. O'Gorman D.B., Weiss J., Hettiaratchi A., Firth S.M., Scott C.D. Insulin-like growth factor-II/mannose 6-phosphate receptor overexpression reduces growth of choriocarcinoma cells in vitro and in vivo. Endocrinology 2002, 143:4287-4294.
47. Penhoat A., Rainey W.E., Viard I., Saez J.M. Regulation of adrenal cell-differentiated functions by growth factors. Horm. Res. 1994, 42:39-43.
48. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer 2008, 8:915-928.
49. Pollak M.N., Schernhammer E.S., Hankinson S.E. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 2004, 4:505-518.
50. Rosenzweig S.A., Atreya H.S. Defining the pathway to insulin-like growth factor system targeting in cancer. Biochem. Pharmacol. 2010, 80:1115-1124.
51. Schmitt A., Saremaslani P., Schmid S., Rousson V., Montani M., Schmid D.M., Heitz P.U., Komminoth P., Perren A. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 2006, 49:298-307.
52. Sell C., Rubini M., Rubin R., Liu J.P., Efstratiadis A., Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc. Natl. Acad. Sci. USA 1993, 90:11217-11221.
53. Shen W., Xian J., Hu W.L., Liu J. Effect of insulin-like growth factor and its receptor-I antibody on growth of human adrenocortical carcinoma SW-13 cell lines in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2007, 27:88-91.
54. Slomiany M.G., Rosenzweig S.A. IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407. Invest. Ophthalmol. Vis. Sci. 2004, 45:2838-2847.
55. Smith L.E., Shen W., Perruzzi C., Soker S., Kinose F., Xu X., Robinson G., Driver S., Bischoff J., Zhang B., Schaeffer J.M., Senger D.R. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 1999, 5:1390-1395.
56. Sookoian S., Gianotti T.F., Gemma C., Burgueno A.L., Pirola C.J. Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension. J. Hypertens. 2010, 28:1194-1202.
57. Weber M.M., Kiess W., Beikler T., Simmler P., Reichel M., Adelmann B., Kessler U., Engelhardt D. Identification and characterization of insulin-like growth factor I (IGF-I) and IGF-II/mannose-6-phosphate (IGF-II/M6P) receptors in bovine adrenal cells. Eur. J. Endocrinol. 1994, 130:265-270.
58. Weber M.M., Simmler P., Fottner C., Engelhardt D. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: interaction with the IGF-I receptor and IGF-binding proteins. Endocrinology 1995, 136:3714-3720.
59. Weber M.M., Auernhammer C.J., Kiess W., Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur. J. Endocrinol. 1997, 136:296-303.
60. Weber M.M., Fottner C., Liu S.B., Jung M.C., Engelhardt D., Baretton G.B. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas. Cancer 2002, 95:2086-2095.
61. Werner H., Maor S. The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action. Trends Endocrinol. Metab. 2006, 17:236-242.
62. Werner H., Shalita-Chesner M., Abramovitch S., Idelman G., Shaharabani-Gargir L., Glaser T. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol. Genet. Metab. 2000, 71:315-320.
63. West A.N., Neale G.A., Pounds S., Figueredo B.C., Rodriguez Galindo C., Pianovski M.A., Oliveira Filho A.G., Malkin D., Lalli E., Ribeiro R., Zambetti G.P. Gene expression profiling of childhood adrenocortical tumors. Cancer Res. 2007, 67:600-608.
64. Wolf E., Hoeflich A., Lahm H. What is the function of IGF-II in postnatal life? Answers from transgenic mouse models. Growth Horm. IGF Res. 1998, 8:185-193.
65. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 2000, 92:1472-1489.
66. Zhu W., Shiojima I., Ito Y., Li Z., Ikeda H., Yoshida M., Naito A.T., Nishi J., Ueno H., Umezawa A., Minamino T., Nagai T., Kikuchi A., Asashima M., Komuro I. IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 2008, 454:345-349.